Türkiye'nin Doğusunda Deri Şarbonu Aile Salgını

Yıl 2015, , 10 - 14, 07.09.2015

Emine Parlak Mehmet Parlak

https://doi.org/10.5505/sakaryamj.2015.87699

Öz

Şarbon tüm dünyada görülebilir. Bu infeksiyon gelişmekte olan ülkelerde endemik bir zoonozdur. Bu yazıda inek kesimine katılan hayvancılıkla uğraşan ve çiftçi olan aynı aileden üç hasta paylaşıldı. Tüm olgular hafif formda deri şarbonu idi. Hastalar antibiyotik ile tedavi edildi. Şarbon Doğu Anadolu için hala büyük bir sağlık problemidir. Erken tanı ve tedavi ile olumlu sonuçlar alınır. Hayvan temas hikâyesi olan hastalarda birlikte veziküler, ağrısız, ödemli lezyonları varsa şarbon göz önünde bulundurulmalıdır. Bu çalışmanın amacı Türkiye'nin Doğu kısmında Erzurum'da deri şarbonu salgınını incelemektir.

Anahtar Kelimeler

şarbon, salgın, zoonoz

Familial Outbreak of Cutaneous Anthrax In Eastern Turkey

Öz

Anthrax can be seen all over the world. This infection is an endemic zoonosis in developing countries. Three patients from the same family who participated in a cow slaughter were farmer and dealing with animal husbandry. All cases were mild form of cutaneous anthrax. The patients were treated with antibiotics. Anthrax is still a major health problem in Eastern Anatolia. That's why early diagnosis and treatment is important for satisfactory results. For the patients who have animal contact history with vesicular, painless and edematous lesions anthrax should be concerned. The aim of this study was to investigate an epidemic of cutaneous anthrax in Erzurum in eastern part of Turkey.

Anahtar Kelimeler

anthrax, outbreak, zoonosis

Kaynakça

• 1. Doganay M, Metan G, Alp E. A review of cutaneous anthrax and its outcome. J Infect Public Health 2010; 3: 98-105.
• 2. Lucey D. Bacillus anthracis (Anthrax), In: Mandell GL, Bennett JE, Dolin R (eds.), Principles and Practice of Infectious Diseases, 6 st ed. Philadelphia: Elsevier-Churchill Livingstone; 2005: p.2485-2493.
• 3. Doganay M, Metan G. Human anthrax in Turkey from 1990 to2007. Vector Borne Zoonotic Dis. 2009; 9: 131-140.
• 4. Hay RJ, Adriaans BM. Bacterial Infections. In: Burns T, Breathnach S, Cox N, Griffiths C (eds.), Rook’s Textbook of Dermatology. 8 th ed. West Sussex, Wiley-Blackwell, 2010; p.30.40-30.41.
• 5. Dixon TC, Meselson M, Guillemin J, Hana PC. Anthrax. N Engl J Med 1999; 341: 815-826.
• 6. Ozkurt Z, Parlak M, Tastan R, Dinler U, Sağlam YS, Ozyurek SF. Anthrax in eastern Turkey, 1992—2004. Emerg Infect Dis 2005; 11: 1939-1941.
• 7. Gülaçtı U, Üstün C, M Ö Erdoğan. A small cutaneous Anthrax epidemic in Eastern Turkey. J Microbiol Infect Dis 2012; 2 (1): 9-13.
• 8. Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon. Medical and public health management. JAMA 1999; 281:1735-1745.
• 9. Kayabas U, Karahocagil MK, Ozkurt Z, et al. Naturally occurring cutaneous anthrax: Antibiotic treatment and outcome. Chemotherapy 2012; 58:34-43.
• 10. CDC. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy. MMWR 2001; 50: 909-919.